Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Y. Lacasse is active.

Publication


Featured researches published by Y. Lacasse.


Toxicology Letters | 1983

Influence of removal from occupational lead exposure on blood and saliva lead concentrations

Jules Brodeur; Y. Lacasse; D. Talbot

Samples of total blood and unstimulated mixed saliva were obtained from 5 male workers occupationally exposed to lead at various time intervals after removal from their work environment. Initial blood lead concentrations were elevated in all workers and then slowly decreased upon removal. Lead concentrations in saliva fell much more abruptly than those in blood, the saliva half-lives being estimated at 5-7 days. Temporary return to work in 2 workers resulted in relatively marked increases of salivary lead concentrations. These results suggest that salivary lead is closely related to recent lead exposure.


Toxicology Letters | 1981

Presence of cadmium in the saliva of adult male workers

Luce Gervais; Y. Lacasse; Jules Brodeur; Alice P'an

Samples of mixed saliva were collected from 16 workers exposed to cadmium dusts and fumes and 19 unexposed co-workers. Samples of total blood and plasma were also obtained. Cadmium (Cd) was measured by flameless atomic absorption spectrometry. Cd was found in higher concentrations in saliva than in blood. The concentration of Cd in saliva was markedly elevated in exposed subjects; the difference was less important in blood. Smokers had more Cd in their blood than non-smokers, but this was not the case for saliva. In vitro studies measuring uptake of Cd by slices of rat submaxillary gland indicated that movement of the metal occurs passively.


Pharmaceutical Research | 1992

Effect of an Acute Dose of Alcohol on the Pharmacokinetics of Oral Nifedipine in Humans

Saeed A. Qureshi; Sylvie Laganière; Gilles Caillé; Denys Gossard; Y. Lacasse; Iain J. McGilveray

Pharmacokinetic and pharmacodynamic interactions of alcohol and nifedipine were assessed in 10 healthy human volunteers. Doses of 20 mg (2 × 10-mg capsules) of nifedipine were administered with either 150 ml of orange juice or 75 ml of alcohol (94%) in 75 ml of orange juice according to a crossover randomized design. Plasma nifedipine levels were monitored for 16 hr after each dosing, along with pulse rate and blood pressure. The relative bioavailability of nifedipine, measured as AUC, was increased by 54% (533 vs 346 ng · hr/ml) after the dose of alcohol (P < 0.0002). However, there were no significant differences between treatments in Cmax,tmax, or t1/2. Although there was no difference in the systolic and diastolic blood pressure and pulse rate between the two treatment groups, the time to reach peak heart rate was significantly faster in the group treated with alcohol (1.4 vs 2.2 hr). This study shows that ethanol increases the bioavailability of nifedipine and decreases the time for onset of increased heart rate.


Biopharmaceutics & Drug Disposition | 1993

Bioavailability of metformin in tablet form using a new high pressure liquid chromatography assay method.

Gilles Caillé; Y. Lacasse; Manon Raymond; Hélène Landriault; Maria Perrotta; Gianfranca Picirilli; Jean Thiffault; Jean Spénard


Biopharmaceutics & Drug Disposition | 1983

Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses

Gilles Caillé; Jean Spénard; Y. Lacasse; J. Brennan


Biopharmaceutics & Drug Disposition | 1984

Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers

Gilles Caillé; P. du Souich; Jean Spénard; Y. Lacasse; Manon Vézina


Pharmaceutical Research | 1994

Pharmacokinetics of Two Enteric-Coated Ketoprofen Products in Humans with or Without Coadministration of Omeprazole and Comparison with Dissolution Findings

Saeed A. Qureshi; Gilles Caillé; Y. Lacasse; Iain J. McGilveray


Biopharmaceutics & Drug Disposition | 1980

Pharmacokinetic characteristics of two different formulations of trimipramine determined with a new GLC method

Gilles Caillé; Jean-Guy Besner; Y. Lacasse; Manon Vézina


Biopharmaceutics & Drug Disposition | 1990

Multiple‐dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat)

A. M. Horvath; D. Pilon; Gilles Caillé; W. A. Colburn; James J. Ferry; G. J. Frank; Y. Lacasse; S. C. Olson


Biopharmaceutics & Drug Disposition | 1980

Pharmacokinetic characteristics of ketoprofen suppositories

Gilles Caillé; Jean-Guy Besner; Y. Lacasse; Manon Vézina

Collaboration


Dive into the Y. Lacasse's collaboration.

Top Co-Authors

Avatar

Gilles Caillé

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Manon Vézina

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Jean Spénard

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jules Brodeur

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

L. Larivière

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

P. du Souich

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alice P'an

Université de Montréal

View shared research outputs
Researchain Logo
Decentralizing Knowledge